Clorox Q1 FY2025: net sales +27% to $1.76B; adj. EPS $1.86 vs $0.49 YoY; raised outlook

CLOROX CO /DE/

2025-Q1 EPS reported $0.80 revenue$1,762,000,000

Diluted EPS rose 371% to $0.80; adjusted EPS of $1.86 (+280% YoY) on strong ops and cyberattack lapping.
Organic sales up 31%; volume growth 26% driven by Health & Wellness (+38%), Household (+43%), Lifestyle (+48%).
Gross margin expanded 740 bps to 45.8% on higher volume and cost savings; FY2025 EPS and margin outlook raised.
Year-to-date operating cash flow $221M vs $20M a year ago; free cash flow $182M vs -$4M.
Better Health VMS divestiture completed Sep 10; one-time charge of $0.94/share in reported EPS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.